Showing results (41-50 of 608) with videos related to
Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 30, 2021
Effectiveness of massage therapy on fatigue and pain in patients with multiple sclerosis: A systematic review and meta-analysisShahin Salarvand, Mohammad Eghbal Heidari, Kazem Farahi, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 30, 2021
Multiple sclerosis in Kenya: Demographic and clinical characteristics of a registry cohortImran Jamal, Jasmit Shah, Peter Mativo, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 16, 2022
Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trialKait F Al, Laura J Craven, Shaeley Gibbons, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 31, 2022
Predictors of positive outcomes following resistive inspiratory muscle training in non-ambulatory persons with advanced multiple sclerosisMin Hui Huang, Lisa Doyle, Alexander Burnham, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Monitoring cognitive change in multiple sclerosis using a computerized cognitive batteryL De Meijer, D Merlo, O Skibina, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 20, 2018
Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulinYuki Matsumoto, Mario Tsuchiya, Shakespear Norshalena, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 8, 2021
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 yearsDana Horáková, Aaron Boster, Antonio Bertolotto, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 6, 2021
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosisKrista D DiSano, Francesca Gilli, Andrew R PachnerMultiple Sclerosis Journal - Experimental, Translational and Clinical|February 18, 2020
Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS onlyS Kalra, C Lowndes, L Durant, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 18, 2020
Corrigendum to Serum hepcidin levels in multiple sclerosisPageof 61